AU
UK
CA
NZ
IND
US
On Wednesday (April 1), the S&P 500 rose to 6,575.32, the Dow advanced to 46,565.74, and the Nasdaq closed at 21,840.95.
The US equity market session onApril 1, 2026, was defined by a violent rotation out of inflation-sensitive commodities and into cyclical growth. Market participants aggressively unwound their defensive and energy-heavy portfolios, choosing instead to fund a broad-based rally led by Industrials and Technology.
The US sector rotation on April 1, 2026, showcased a dramatic structural shift. As the momentum chart illustrates, the market is aggressively unwinding its concentrated Energy positioning and redistributing that capital back into cyclical growth and technology. The synchronized leftward drift seen in previous …
S&P 500 Daily Price Chart. Source: tradingview.com, Analysis by Kalkine Group
Trendline Support: Early Signs of StabilitySanDisk Corp. has recently shown signs of resilience after finding support at a well-defined rising trendline. This technical level has acted as a cushion for the stock, preventing further downside and allowing prices to drift higher in the near …
Micron Technology shares have staged a modest rebound after finding support at a falling trendline, offering bulls a moment of relief in what has otherwise been a bruising stretch for the memory chipmaker. But technical analysts caution against reading too much into the recovery …
PepGen (NASDAQ: PEPG) suffered one of the biotechnology sector's most severe single-session declines of the year on April 1st, with shares closing down 59% at $1.74 after Phase 2 trial data for its lead programme in myotonic dystrophy type 1 failed to demonstrate the …
Cyclerion Therapeutics (NASDAQ: CYCN)is effectively ceding its identity in a definitive all-stock merger with privately held Korsana Biosciences, with the combined entity set to trade on Nasdaq under the new tickerKRSA. The transaction arrives backed by an oversubscribed $380 million private financing round led …
Cyclerion Therapeutics (NASDAQ: CYCN)is effectively ceding its identity in a definitive all-stock merger with privately held Korsana Biosciences, with the combined entity set to trade on Nasdaq under the new tickerKRSA. The transaction arrives backed by an oversubscribed $380 million private financing round led …
Please wait processing your request...